AMGN

Amgen

$287.71

+2.1 (+0.74%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 30.08.2025
$311.88
(+8.4%)
Strong Buy: 2
Buy: 12
Hold: 15
Sell: 2
Strong Sell: 1
Description:
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.
Exchange:
NASDAQ
Country:
USA
Sector:
LIFE SCIENCES
Industry:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address:
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, US
Fiscal year end:
December
Market capitalization:
$154 Billion
EBITDA:
$16.1 Billion
PERatio:
23.37
EPS:
12.22
Dividend per share:
$9.26
Dividend yield:
3.22%
Beta:
0.48

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+124%
How much will you get:
$2,237
Prices dates:
31-07-2015: $131.93 and 31-07-2025: $295.10